Development of A Large Scale Asymmetric Synthesis of the Glucocorticoid Agonist Bi 653048 Bs H3po4
Jonathan T. Reeves,Daniel R. Fandrick,Zhulin Tan,Jinhua J. Song,Sonia Rodriguez,Bo Qu,Soojin Kim,Oliver Niemeier,Zhibin Li,Denis Byrne,Scot Campbell,Ashish Chitroda,Phil DeCroos,Thomas Fachinger,Victor Fuchs,Nina C. Gonnella,Nelu Grinberg,Nizar Haddad,Burkhard Jaeger,Heewon Lee,Jon C. Lorenz,Shengli Ma,Bikshandarkoil A. Narayanan,Larry J. Nummy,Ajith Premasiri,Frank Roschangar,Max Sarvestani,Sherry Shen,Earl Spinelli,Xiufeng Sun,Richard J. Varsolona,Nathan Yee,Michael Brenner,Chris H. Senanayake
DOI: https://doi.org/10.1021/jo400079z
2013-01-01
Abstract:The development of a large scale synthesis of the glucocorticoid agonist BI 653048 BS H3PO4 (1 center dot H3PO4) is presented. A key trifluoromethyl ketone intermediate 22 containing an N-(4-methoxyphenyl)ethyl amide was prepared by an enolization/bromine-magnesium exchange/electrophile trapping reaction. A nonselective propargylation of trifluoromethyl ketone 22 gave the desired diastereomer in 32% yield and with dr = 98:2 from a 1:1 diastereomeric mixture after crystallization. Subsequently, an asymmetric propargylation was developed which provided the desired diastereomer in 4:1 diastereoselectivity and 75% yield with dr = 99:1 after crystallization. The azaindole moiety was efficiently installed by a one pot cross coupling/indolization reaction. An efficient deprotection of the 4-methoxyphenethyl group was developed using H3PO4/anisole to produce the anisole solvate of the API in high yield and purity. The final form, a phosphoric acid cocrystal, was produced in high yield and purity and with consistent control of particle size.